Healthcare Professionals

Proveca medicines for children

This section is intended for Healthcare Professionals only and contains promotional content.

Sialanar® received a Paediatric Use Marketing Authorisation (PUMA) in September 2016 for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

Sialanar® Prescribing Information
Sialanar® Information HPRA

If you would like to find out further information on Sialanar® (including various educational and supporting resources) please visit the Sialanar® website.

Please see information below to report adverse events in the Republic of Ireland

Adverse events should be reported. Reporting forms and information can be found at:
Adverse events should also be reported to Proveca Limited.
Phone: +44 333 200 1866 E-mail: